BHARAT IMMUNOLOGICALS & BIOLOG (BIBCL)

BSE: ₹17.52
Stock Performance
Corporate Announcements
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI’S LODR.

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 16th August 2024 for General Purpose.

2024-08-07 16:58:26
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI’S LODR.

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 08th March 2024 for General Purpose.

2024-02-29 16:57:20
Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.

Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023. Submitted for kind information and record please.

2023-11-28 13:53:33
2023-11-01 17:58:09
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 31St October 2023 Under Regulation 29 Of SEBI’S LODR.

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 31st October 2023, to approve the quarterly financial results of the Company for the quarters ended 30th June and 30th September 2023.

2023-10-19 15:55:31
Submission Of Annual Accounts For The Financial Year Ended On 31.03.2023 And Is Under Audit Of Statutory Auditor Appointed By C&AG

The Annual Accounts i.e. the Balance Sheet and Statement of Profit & Loss account approved by Board in its meeting held on 24.04.2023 and provided to Statutory Auditors for the year ended 31.03.2023 is being submitted at exchange within prescribed time i.e on 31.5.2023 for consideration of compliance please

2023-05-31 14:52:16

Quarterly Financials

Consolidated Standalone
Particulars Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Jun 2020 Sep 2020 Dec 2020 Sep 2021 Dec 2021 Sep 2022 Dec 2022
Revenue from Operations 8.28 70.61 7.00 8.10 28.48 19.15 25.36 25.20 24.70 17.43 26.48 0.00
YOY Revenue Growth % - - 7973.59% 73.39% 243.98% -72.87% 262.27% 211.05% -13.28% -8.99% 4.42% -100%
Other Income 0.10 2.09 1.84 0.17 0.47 -0.58 0.14 1.20 0.22 0.12 0.32 0.10
Total Income 8.38 72.70 8.84 8.28 28.96 18.57 25.50 26.40 24.92 17.55 26.80 0.10
Total Expenses + 8.36 75.83 13.84 16.10 32.16 19.67 31.08 28.83 29.48 18.32 30.76 6.43
Cost of Materials Consumed 18.45 50.17 3.24 44.53 42.82 21.41 19.82 12.00 14.20 19.78 0.11 6.51
Employee Benefit Expense 2.32 2.54 2.56 2.55 2.68 1.58 3.47 2.64 3.05 3.19 3.95 4.10
Other Expenses 1.07 5.10 3.14 2.01 3.46 3.13 3.14 1.89 3.18 4.27 0.65 1.95
Operating Profit -0.08 -5.22 -6.84 -8.00 -3.67 -0.52 -5.72 -3.63 -4.78 -0.89 -4.28 -6.43
OPM % -1% -7.4% -97.8% -98.7% -12.9% -2.7% -22.6% -14.4% -19.3% -5.1% -16.2% 0%
Profit Before Tax + 0.02 -3.13 -5.00 -7.82 -3.20 -1.10 -5.59 -2.43 -4.56 -0.77 -3.96 -6.33
Tax Expense 0.00 -0.89 -1.54 -2.16 -0.85 -0.32 -1.72 -0.53 4.80 -0.11 -0.88 -1.65
Tax % 14.9% - - - - - - - - - - -
Profit After Tax 0.02 -2.24 -3.46 -5.66 -2.35 -0.78 -3.87 -1.89 -9.36 -0.66 -3.08 -4.68
EPS (Basic) -0.58 -0.52 -0.80 -1.28 -0.54 -0.18 -0.90 -0.44 -2.17 -0.08 -0.71 -1.08

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2019
Revenue from Operations 83.65
YOY Revenue Growth % -
Other Income 2.64
Total Income 86.28
Total Expenses + 94.33
Cost of Materials Consumed 86.62
Employee Benefit Expense 9.38
Other Expenses 9.91
Operating Profit -10.69
OPM % -12.8%
Profit Before Exceptional -8.05
Exceptional Items 0.00
Profit Before Tax + -8.05
Tax Expense -2.50
Tax % -
Profit After Tax -5.55
EPS (Basic) -1.29

Balance Sheet

Particulars Mar 2019
ASSETS
Non-Current Assets + 14.24
Property, Plant & Equipment 4.69
Capital Work in Progress 0.22
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 107.14
Inventories 14.44
Trade Receivables 72.97
Cash and Cash Equivalents 0.41
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 29.10
Equity Share Capital 43.18
Other Equity -14.08
Non-Current Liabilities 3.80
Current Liabilities 88.49
Total Liabilities 92.29

Cash Flow Statement

Particulars Mar 2019
Cash from Operating Activities 0.00
Cash from Investing Activities 0.00
Cash from Financing Activities 0.00
Net Increase/Decrease in Cash 0.00